Altimmune, Inc. (ALT)
3.005
-0.25
(-7.68%)
USD |
NASDAQ |
May 07, 13:22
Altimmune SG&A Expense (TTM) : 28.10M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.56B |
| Amgen, Inc. | 6.965B |
| Madrigal Pharmaceuticals, Inc. | 645.95M |
| CorMedix, Inc. | 99.77M |
| Viking Therapeutics, Inc. | 48.28M |